ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
European Commission approves dispersible tablets to treat paediatric HIV
January 14, 2021Marketing authorisation in the EU has been given to Tivicay (dolutegravir) dispersible tablets to treat HIV in certain paediatric patients. -
FDA approves ViiV Healthcare’s Tivicay to treat HIV in children
June 16, 2020ViiV Healthcare has received approval from the US Food and Drug Administration (FDA) for Tivicay PD (dolutegravir) tablets, in combination with other antiretroviral agents, to treat children with human immunodeficiency virus type 1 (HIV-1) infection. -
FDA approves drug to treat infants and children with HIV
June 15, 2020The safety and effectiveness of Tivicay and Tivicay PD were supported by a trial that included 75 HIV-1–infected infants, children and adolescents four weeks to less than 18 years old.
Pharma Sources Insight January 2025
